Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · June 11, 2024

Nivolumab Plus Ipilimumab for Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Annals of Oncology


Additional Info

Annals of Oncology
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
Ann. Oncol 2024 May 22;[EPub Ahead of Print], I Melero, T Yau, YK Kang, et al

Further Reading